Tandem Diabetes Care (TNDM) Other financing activities (2016 - 2024)

Tandem Diabetes Care has reported Other financing activities for 4 years, with the latest figure at $183000.0 in Q1 2024.

• For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $183000.0; the trailing twelve-month figure through Dec 2024 stood at $183000.0 (up 357.75% YoY), and the FY2024 full-year result was $183000.0, up 357.75% from the prior year.
• Other financing activities for Q1 2024 stood at $183000.0, up from -$71000.0 in the prior quarter.
• The five-year high for Other financing activities was $183000.0 in Q1 2024, with the low at -$405000.0 in Q3 2022.
• Historically, Other financing activities has averaged -$52500.0 across 3 years, with a median of $6000.0 in 2022.
• The largest YoY upside for Other financing activities was 82.47% in 2023 against a maximum downside of 82.47% in 2023.
• Tandem Diabetes Care's Other financing activities stood at $83000.0 in 2022, then sank by 185.54% to -$71000.0 in 2023, then surged by 357.75% to $183000.0 in 2024.
• The last three Other financing activities figures came in at $183000.0 (Q1 2024), -$71000.0 (Q3 2023), and $83000.0 (Q4 2022), per Business Quant data.